US Stock MarketDetailed Quotes

DNTH Dianthus Therapeutics

Watchlist
  • 20.810
  • +0.040+0.19%
Trading Nov 21 13:16 ET
615.91MMarket Cap-9107P/E (TTM)

Dianthus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
135.06%2.17M
92.26%1.86M
83.61%874K
-55.96%2.83M
-61.11%457K
-21.23%924K
969K
476K
334.76%6.42M
1.18M
Operating revenue
135.06%2.17M
92.26%1.86M
83.61%874K
-55.96%2.83M
-61.11%457K
-21.23%924K
--969K
--476K
334.76%6.42M
--1.18M
Cost of revenue
Gross profit
Operating expense
92.24%32.07M
88.83%24.07M
129.42%18.72M
41.19%51M
13.02%13.41M
76.97%16.68M
12.75M
8.16M
148.06%36.12M
11.87M
Selling and administrative expenses
-25.16%6.53M
140.65%6M
143.94%5.64M
169.30%18.16M
127.39%4.63M
294.88%8.72M
--2.49M
--2.31M
244.73%6.74M
--2.04M
-General and administrative expense
-25.16%6.53M
140.65%6M
143.94%5.64M
169.30%18.16M
127.39%4.63M
294.88%8.72M
--2.49M
--2.31M
244.73%6.74M
--2.04M
Research and development costs
220.90%25.54M
76.24%18.07M
123.67%13.08M
11.78%32.84M
-10.68%8.78M
10.28%7.96M
--10.25M
--5.85M
133.06%29.38M
--9.83M
Operating profit
-89.73%-29.9M
-88.55%-22.2M
-132.25%-17.84M
-62.17%-48.17M
-21.16%-12.96M
-90.93%-15.76M
-11.78M
-7.68M
-127.00%-29.71M
-10.69M
Net non-operating interest income expense
332.81%4.45M
585.30%4.71M
596.70%4.22M
316.07%4.76M
281.88%2.44M
146.88%1.03M
687K
606K
38,066.67%1.15M
640K
Non-operating interest income
332.81%4.45M
585.30%4.71M
596.70%4.22M
316.07%4.76M
281.88%2.44M
146.88%1.03M
--687K
--606K
38,066.67%1.15M
--640K
Other net income (expense)
1,006.45%281K
-117.65%-111K
-950.00%-126K
-272.62%-145K
19.05%-51K
-157.41%-31K
-51K
-12K
423.08%84K
-63K
Gain on sale of security
1,718.75%259K
-10.71%-31K
-33.33%-12K
-162.50%-85K
-60.00%-32K
-128.57%-16K
---28K
---9K
623.08%136K
---20K
Other non- operating income (expenses)
246.67%22K
-247.83%-80K
-3,700.00%-114K
-15.38%-60K
55.81%-19K
-650.00%-15K
---23K
---3K
---52K
---43K
Income before tax
-70.52%-25.17M
-58.05%-17.61M
-93.93%-13.75M
-52.95%-43.56M
-4.42%-10.56M
-89.66%-14.76M
-11.14M
-7.09M
-117.22%-28.48M
-10.12M
Income tax
Net income
-70.52%-25.17M
-58.05%-17.61M
-93.93%-13.75M
-52.95%-43.56M
-4.42%-10.56M
-89.66%-14.76M
-11.14M
-7.09M
-117.22%-28.48M
-10.12M
Net income continuous Operations
-70.52%-25.17M
-58.05%-17.61M
-93.93%-13.75M
-52.95%-43.56M
-4.42%-10.56M
-89.66%-14.76M
---11.14M
---7.09M
-117.22%-28.48M
---10.12M
Minority interest income
Net income attributable to the parent company
-70.52%-25.17M
-58.05%-17.61M
-93.93%-13.75M
-52.95%-43.56M
-4.42%-10.56M
-89.66%-14.76M
-11.14M
-7.09M
-117.22%-28.48M
-10.12M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-70.52%-25.17M
-58.05%-17.61M
-93.93%-13.75M
-52.95%-43.56M
-4.42%-10.56M
-89.66%-14.76M
-11.14M
-7.09M
-117.22%-28.48M
-10.12M
Basic earnings per share
80.42%-0.74
32.16%-0.51
-12.87%-0.54
-339.70%-8.45
-4.42%-0.7129
-619.56%-3.78
-0.7518
-0.4784
-117.22%-1.9218
-0.6827
Diluted earnings per share
80.42%-0.74
32.16%-0.51
-12.87%-0.54
-339.70%-8.45
-4.42%-0.7129
-619.56%-3.78
-0.7518
-0.4784
-117.22%-1.9218
-0.6827
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 135.06%2.17M92.26%1.86M83.61%874K-55.96%2.83M-61.11%457K-21.23%924K969K476K334.76%6.42M1.18M
Operating revenue 135.06%2.17M92.26%1.86M83.61%874K-55.96%2.83M-61.11%457K-21.23%924K--969K--476K334.76%6.42M--1.18M
Cost of revenue
Gross profit
Operating expense 92.24%32.07M88.83%24.07M129.42%18.72M41.19%51M13.02%13.41M76.97%16.68M12.75M8.16M148.06%36.12M11.87M
Selling and administrative expenses -25.16%6.53M140.65%6M143.94%5.64M169.30%18.16M127.39%4.63M294.88%8.72M--2.49M--2.31M244.73%6.74M--2.04M
-General and administrative expense -25.16%6.53M140.65%6M143.94%5.64M169.30%18.16M127.39%4.63M294.88%8.72M--2.49M--2.31M244.73%6.74M--2.04M
Research and development costs 220.90%25.54M76.24%18.07M123.67%13.08M11.78%32.84M-10.68%8.78M10.28%7.96M--10.25M--5.85M133.06%29.38M--9.83M
Operating profit -89.73%-29.9M-88.55%-22.2M-132.25%-17.84M-62.17%-48.17M-21.16%-12.96M-90.93%-15.76M-11.78M-7.68M-127.00%-29.71M-10.69M
Net non-operating interest income expense 332.81%4.45M585.30%4.71M596.70%4.22M316.07%4.76M281.88%2.44M146.88%1.03M687K606K38,066.67%1.15M640K
Non-operating interest income 332.81%4.45M585.30%4.71M596.70%4.22M316.07%4.76M281.88%2.44M146.88%1.03M--687K--606K38,066.67%1.15M--640K
Other net income (expense) 1,006.45%281K-117.65%-111K-950.00%-126K-272.62%-145K19.05%-51K-157.41%-31K-51K-12K423.08%84K-63K
Gain on sale of security 1,718.75%259K-10.71%-31K-33.33%-12K-162.50%-85K-60.00%-32K-128.57%-16K---28K---9K623.08%136K---20K
Other non- operating income (expenses) 246.67%22K-247.83%-80K-3,700.00%-114K-15.38%-60K55.81%-19K-650.00%-15K---23K---3K---52K---43K
Income before tax -70.52%-25.17M-58.05%-17.61M-93.93%-13.75M-52.95%-43.56M-4.42%-10.56M-89.66%-14.76M-11.14M-7.09M-117.22%-28.48M-10.12M
Income tax
Net income -70.52%-25.17M-58.05%-17.61M-93.93%-13.75M-52.95%-43.56M-4.42%-10.56M-89.66%-14.76M-11.14M-7.09M-117.22%-28.48M-10.12M
Net income continuous Operations -70.52%-25.17M-58.05%-17.61M-93.93%-13.75M-52.95%-43.56M-4.42%-10.56M-89.66%-14.76M---11.14M---7.09M-117.22%-28.48M---10.12M
Minority interest income
Net income attributable to the parent company -70.52%-25.17M-58.05%-17.61M-93.93%-13.75M-52.95%-43.56M-4.42%-10.56M-89.66%-14.76M-11.14M-7.09M-117.22%-28.48M-10.12M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -70.52%-25.17M-58.05%-17.61M-93.93%-13.75M-52.95%-43.56M-4.42%-10.56M-89.66%-14.76M-11.14M-7.09M-117.22%-28.48M-10.12M
Basic earnings per share 80.42%-0.7432.16%-0.51-12.87%-0.54-339.70%-8.45-4.42%-0.7129-619.56%-3.78-0.7518-0.4784-117.22%-1.9218-0.6827
Diluted earnings per share 80.42%-0.7432.16%-0.51-12.87%-0.54-339.70%-8.45-4.42%-0.7129-619.56%-3.78-0.7518-0.4784-117.22%-1.9218-0.6827
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data